Search Results

An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...

These tables are special analyses that include opioid use (or heroin use and prescription pain reliever misuse) or opioid use disorders as a variable. The NSDUH survey years used, as well as by-demographic group analyses, vary.

This national report summarizes key findings from the 2016 National Survey on Drug Use and Health (NSDUH) for indicators of substance use and mental health among people aged 12 years old or older in the civilian, noninstitutionalized population of the United States. Estimates include tobacco use, alcohol use, illicit drug...

This report uses the combined 2007 to 2012 National Surveys on Drug Use and Health (NSDUHs), the 2012 Treatment Episode Data Set (TEDS), and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to examine opioid use and treatment among women of childbearing age (aged 15 to 44).

This spotlight uses 2013 The Treatment Episode Data Set (TEDS) to examine substance abuse treatment admissions among veterans and nonveterans. Substance abuse treatment admissions were analyzed for alcohol, heroin, cocaine, marijuana, methamphetamine, and other opioids and synthetics.

This report looks at costs for substance use disorder treatment reported in the 2010 National Ambulatory Medical Care Survey. These data include costs for prescriptions for medications and behavioral treatment used to treat alcohol use disorders and opioid use disorders made in office visits to general and family practice physicians...

This short report examines emergency department (ED) visits involving benzodiazepines, which are medications prescribed to relieve symptoms of anxiety, panic attacks and seizures. It looks at the effect of combining benzodiazepines with opioid pain relievers or alcohol, both substances that also depress the central nervous system. The report quantifies the...